SlideShare a Scribd company logo
1 of 30
DR MOHD SHAHID
DEPARTMENT OF MOLAJAT
NIUM, BANGALORE
 BMC Complementary and Alternative Medicine is an
open access, peer-reviewed journal that considers
articles on interventions and resources that complement
or replace conventional therapies, with a specific
emphasis on research that explores the biological
mechanisms of action, as well as their
efficacy, safety, costs, patterns of use and/or
implementation
 Impact Factor : 2.08
 ISSN: 1472-6882
 BioMed Central is an STM (Science, Technology and
Medicine) publisher of 258 peer-reviewed open access
journals.
 BioMed Central Floor 6, 236 Gray's Inn Road London
WC1X 8HB United Kingdom Email:
info@biomedcentral.com Customer Services:
Customers in the UK call free on 0800 389 8136 All
other customers call +44 (0) 20 3192 2009 (weekdays
9am - 6pm UK time) Fax: +44 (0)20 3192 2010
 Indexing services
All articles published in BMC Complementary
and Alternative Medicine are included in
PubMed, the most widely used biomedical
bibliographic database service, which is run by
the US National Library of Medicine
 Other bibliographic databases
 Google Scholar
 MEDLINE
 PubMed Central
 SOCOLAR
 SpringerLink
 Thomson Reuters (ISI) etc...
Received: 16 Nov 2012
Accepted: 01 Nov 2013
Published: 13 Nov 2013
 A randomized, controlled
cross-over trial of dermally-
applied lavender (Lavandula
angustifolia) oil as a
treatment of agitated
behaviour in dementia
 Informative ?
 Self Explanatory ?
 Variables are Specific ?
 Daniel W O’Connor*
 Barbara Eppingstall
 John Taffe
 Eva S van der Ploeg
 *Correspondence: Daniel.OConnor@monash.edu
School of Psychology and Psychiatry, Monash
University, Kingston Centre, Warrigal
Road, Cheltenham, Victoria 3192, Australia
Competent ?
Degree and Designations ?
E mail is mentioned
 A progressive, irreversible decline in mental
function, marked by memory impairment
and, often, deficits in reasoning, judgment, abstract
thought, registration, comprehension, learning, task
execution, and use of language
 In the U.S., 4.5 million people are afflicted by
dementia. The prevalence is esp. high in the very
elderly: about 20% to 40% of those over 85 are
demented
 Dementia is somewhat more common in women than in
men
 Synonym L.
officinalis Chaix. L.
spica Linn.
 Family Labiatae;
Lamiaceae.
 Habitat Native to
Mediterranean
region; cultivated in
Jammu and Kashmir
 English name:
Lavender
 Action Herb—mildly sedative, antiflatulent and
cholagogue. Essential oil—
antiseptic, antibacterial, antispasmodic.
 Major constituents of the essential oil are linalool and
linalyl acetate.
 Family Papilionaceae;
Fabaceae.
 Habitat
Mediterranean region
and Asia Minor. Dried
plant and flowers are
imported into Mumbai
from Persian Gulf
 English Arabian or
French: Lavender
 Unani:
Ustukhuddus, Alfaajan
 Folk: Dhaaru
 Action Flowers—
antidepressive, sedative, anticonvulsant, carminative, a
ntispasmodic, antibacterial, antiseptic. Used in
depression, nervous headache, sluggish
circulation, physical and mental
exhaustion, insomnia, epilepsy, neuralgia and
rheumatic affections
 Plant—used for the treatment of epilepsy and chronic
sinusitis in Unani medicine.
 BACKGROUND clearly mentioned
 Objective is clearly stated (want to know efficacy of
test drug )
 It is a Randomized, single blind cross-over
trial, mentioned in abstract
 Study design is also given in abstract
 Hypothesis is declare
 Results also mentioned clearly that test drug is not
significant against the conrol drug
 Trial registration also stated (ACTRN)
 Conclusion is comprehensible
 Within the word limit
 Purpose of study is well defined
Within word limits
Appropriate
 Prevalence missing of dementia
 More emphasis on Lavender
 Wonderfully describe why they choose test drug
with proper references.
 One study quted, that describe the efficacy is
equal to lorazepam0.5 mg
 Literature review provided
 Aim of study is mentioned
 Astonishingly discussed about previous study
 Need of study is mentioned
 Purpose of study is mentioned but why they choose
fore arm massage instead of head or any other part
of the body, not declared
 Palace of study point out, and also from where the
participants enrolled (8 specialist Psychogeriatric
nursing home and 3 private nursing home in
Melbourne)
 Diagnostic criteria is declare, with REFERENCE
(CLINICAL DEMENTIA RATING SCALE)
 Inclusion & Exclusion criteria Stated
 Test drug & dosage are mentioned properly, WHY
THIS DRUG---- REFERENCES given
 Duration of study mentioned between 2009 and 2011)
 Study protocol approved by IEC
 Test drug choose after electrophysical analysis in
Department of Pharmacology and Toxicology, Otago
University, New Zealand
 Not describe the control drug (just
stated neutral control oil)
 Follow up & total number of patient screened declared
 Drop outs declared, with REASONS
 Randomization done through
Exel random number generator
 Duration of protocol is also declared, that is both
intervention comprised 3 exposures over a one week
with 4 days washout period and the trial was limited to
2 week
 Sample size declared
 Group A: total allocated patients 38, number of patients
complete the intervention are 37
 Group B ; total allocated patients 28, number of
patients complete the intervention are 27
 Written consent was taken from the next of Kin or legal
guardians
 Study design mentioned
 Subjective and Objective criteria point out
 Tables are clearly defined, with Graphical
representation
 Analysis are made through
1. Two sided hypothesis test with Type I error rate 0.05
and power set to 90
2. Binomial regression test
 Discussion about the result are justified
 Mention the limitation of study
1. Product varialbility
2. Limited knowledge base of lavender’s
pharmacological properties
3. Dosing strategies are based largely on traditional
practice
 Unambiguously declare that Studies of essential oils
are constrained by their variable formulations and
uncertain pharmacokinetics and so optimal dosing
and delivery regimens remain speculative.
 However this, topically delivered, high strength, pure
lavender oil had no discernible effect on affect and
behaviour in a well-defined clinical sample.
 Acknowledgements are declare
 Funding: By National Health and Medical Research
Council and the Dementia Collaborative Reasearch
Centre administered through the University of New
South Wales. Neither funding body, nor the supplier of
materials, played any part in analysing data and
preparing this report.
 Reference according to the journal guidelines
 This is wonderful example that how to done and write a
standard paper
 For me, this is the way to approach a study before
going to conduct it
 They have given every answers before you raise any
question
 Wonderful paper
Always welcome at
drshahidkhan2005@gmail.com
Thanks for your
patience
Open For Discussion

More Related Content

What's hot

Reverse pharmacology trad-mal
Reverse pharmacology trad-malReverse pharmacology trad-mal
Reverse pharmacology trad-mal22SPMB
 
Therapeutic drug monitoring
Therapeutic drug monitoring Therapeutic drug monitoring
Therapeutic drug monitoring Kirsha K S
 
Reverse Pharmacology
Reverse Pharmacology Reverse Pharmacology
Reverse Pharmacology Ravindra Gade
 
phase 1 clinical trial
phase 1 clinical trialphase 1 clinical trial
phase 1 clinical trialJyoti Sharma
 
Summer Intership Training Ppt
Summer Intership Training PptSummer Intership Training Ppt
Summer Intership Training Pptsarotri
 
Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)elsanimadhan
 
Medication adherence
Medication adherenceMedication adherence
Medication adherenceChanda Ranjan
 
Rational drug, Essential drugs.pptx
Rational drug, Essential drugs.pptxRational drug, Essential drugs.pptx
Rational drug, Essential drugs.pptxManoj Kumar
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTZeshan Ahmed
 
P drugs for given case
P drugs for given caseP drugs for given case
P drugs for given casekopalsharma85
 
Fixed dose combination
Fixed dose combinationFixed dose combination
Fixed dose combinationPriya Nigan
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 rBhaswat Chakraborty
 
Repurposed drugs and safety monitoring
Repurposed drugs and safety monitoring Repurposed drugs and safety monitoring
Repurposed drugs and safety monitoring PHARMAQUEST Vydehi
 

What's hot (19)

Therapeutic drug monitoring
Therapeutic  drug monitoringTherapeutic  drug monitoring
Therapeutic drug monitoring
 
Reverse pharmacology trad-mal
Reverse pharmacology trad-malReverse pharmacology trad-mal
Reverse pharmacology trad-mal
 
Therapeutic drug monitoring
Therapeutic drug monitoring Therapeutic drug monitoring
Therapeutic drug monitoring
 
BCATSfinal
BCATSfinalBCATSfinal
BCATSfinal
 
Reverse Pharmacology
Reverse Pharmacology Reverse Pharmacology
Reverse Pharmacology
 
phase 1 clinical trial
phase 1 clinical trialphase 1 clinical trial
phase 1 clinical trial
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Summer Intership Training Ppt
Summer Intership Training PptSummer Intership Training Ppt
Summer Intership Training Ppt
 
Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Rational drug, Essential drugs.pptx
Rational drug, Essential drugs.pptxRational drug, Essential drugs.pptx
Rational drug, Essential drugs.pptx
 
Reverse pharmacology
Reverse pharmacologyReverse pharmacology
Reverse pharmacology
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETT
 
P medicine
P medicineP medicine
P medicine
 
P drugs for given case
P drugs for given caseP drugs for given case
P drugs for given case
 
Fixed dose combination
Fixed dose combinationFixed dose combination
Fixed dose combination
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 r
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Repurposed drugs and safety monitoring
Repurposed drugs and safety monitoring Repurposed drugs and safety monitoring
Repurposed drugs and safety monitoring
 

Similar to Jounral club presentation on 22 march 2014 in NATIONAL INSTITUTE OF UNANI MEDICINE, BANGALORE

BARRIERS IN HERBAL DRUGS CLINICAL TRIAL
BARRIERS IN HERBAL DRUGS CLINICAL TRIALBARRIERS IN HERBAL DRUGS CLINICAL TRIAL
BARRIERS IN HERBAL DRUGS CLINICAL TRIALHerb Cyte
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyHA VO THI
 
Everything You'll Ever Need to Know about OTCs and Self Care
Everything You'll Ever Need to Know about OTCs and Self CareEverything You'll Ever Need to Know about OTCs and Self Care
Everything You'll Ever Need to Know about OTCs and Self CareShayne McKee
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdfAmeena Kadar
 
Application of quality control principles to herbal drugs
Application of quality control principles to herbal drugsApplication of quality control principles to herbal drugs
Application of quality control principles to herbal drugsNarongchai Pongpan
 
Herbal medicines overview
Herbal medicines overviewHerbal medicines overview
Herbal medicines overviewpharmaindexing
 
AETCOM all competencies.pptx pathology practical
AETCOM  all competencies.pptx pathology practicalAETCOM  all competencies.pptx pathology practical
AETCOM all competencies.pptx pathology practical59w4pymhcm
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxSHIVANEE VYAS
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug informationArvind Kumar
 
Evidence based medicine and tdm
Evidence based medicine and tdmEvidence based medicine and tdm
Evidence based medicine and tdmNaser Tadvi
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”Fred Jorgensen
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”Fred Jorgensen
 
Randomized clinical trials
Randomized clinical trialsRandomized clinical trials
Randomized clinical trialsAhmed Nouri
 
Clinical study of plant derived medicine
Clinical study of plant derived medicineClinical study of plant derived medicine
Clinical study of plant derived medicinevishvanath vaidya
 
How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyDrpradeepthi
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxMokshada Bhirud
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdfUVAS
 

Similar to Jounral club presentation on 22 march 2014 in NATIONAL INSTITUTE OF UNANI MEDICINE, BANGALORE (20)

BARRIERS IN HERBAL DRUGS CLINICAL TRIAL
BARRIERS IN HERBAL DRUGS CLINICAL TRIALBARRIERS IN HERBAL DRUGS CLINICAL TRIAL
BARRIERS IN HERBAL DRUGS CLINICAL TRIAL
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderly
 
Everything You'll Ever Need to Know about OTCs and Self Care
Everything You'll Ever Need to Know about OTCs and Self CareEverything You'll Ever Need to Know about OTCs and Self Care
Everything You'll Ever Need to Know about OTCs and Self Care
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
 
Application of quality control principles to herbal drugs
Application of quality control principles to herbal drugsApplication of quality control principles to herbal drugs
Application of quality control principles to herbal drugs
 
Herbal medicines overview
Herbal medicines overviewHerbal medicines overview
Herbal medicines overview
 
Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
 
AETCOM all competencies.pptx pathology practical
AETCOM  all competencies.pptx pathology practicalAETCOM  all competencies.pptx pathology practical
AETCOM all competencies.pptx pathology practical
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
Evidence based medicine and tdm
Evidence based medicine and tdmEvidence based medicine and tdm
Evidence based medicine and tdm
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
 
Capstone assignment 04
Capstone assignment 04Capstone assignment 04
Capstone assignment 04
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
Randomized clinical trials
Randomized clinical trialsRandomized clinical trials
Randomized clinical trials
 
Clinical study of plant derived medicine
Clinical study of plant derived medicineClinical study of plant derived medicine
Clinical study of plant derived medicine
 
How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical Pharmacy
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
 

More from MOHD SHAHID

Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)
Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)
Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)MOHD SHAHID
 
Unani system of medicine – a hope for post stroke disability presented in delhi
Unani system of medicine – a hope for post stroke disability presented in delhiUnani system of medicine – a hope for post stroke disability presented in delhi
Unani system of medicine – a hope for post stroke disability presented in delhiMOHD SHAHID
 
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)MOHD SHAHID
 
Hijama (cupping) therapy an overview by Dr MOHD SHAHID (MD)
Hijama (cupping) therapy   an overview by Dr MOHD SHAHID (MD) Hijama (cupping) therapy   an overview by Dr MOHD SHAHID (MD)
Hijama (cupping) therapy an overview by Dr MOHD SHAHID (MD) MOHD SHAHID
 
Journal club presentation on 05 oct 13
Journal club  presentation on 05 oct 13Journal club  presentation on 05 oct 13
Journal club presentation on 05 oct 13MOHD SHAHID
 
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi and
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi andEfficacy of munzij wa mushil e-balgham, majoon-e-hindi and
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi andMOHD SHAHID
 
Management of ischeamic heart disease in light of advia qalbia
Management of ischeamic heart disease in light of advia qalbiaManagement of ischeamic heart disease in light of advia qalbia
Management of ischeamic heart disease in light of advia qalbiaMOHD SHAHID
 

More from MOHD SHAHID (7)

Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)
Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)
Cancer perception in Unani medicine (ONE OF AYUSH SYSTEM)
 
Unani system of medicine – a hope for post stroke disability presented in delhi
Unani system of medicine – a hope for post stroke disability presented in delhiUnani system of medicine – a hope for post stroke disability presented in delhi
Unani system of medicine – a hope for post stroke disability presented in delhi
 
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)
Hijama (cupping) therapy - an overview by DR MOHD SHAHID (MD)
 
Hijama (cupping) therapy an overview by Dr MOHD SHAHID (MD)
Hijama (cupping) therapy   an overview by Dr MOHD SHAHID (MD) Hijama (cupping) therapy   an overview by Dr MOHD SHAHID (MD)
Hijama (cupping) therapy an overview by Dr MOHD SHAHID (MD)
 
Journal club presentation on 05 oct 13
Journal club  presentation on 05 oct 13Journal club  presentation on 05 oct 13
Journal club presentation on 05 oct 13
 
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi and
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi andEfficacy of munzij wa mushil e-balgham, majoon-e-hindi and
Efficacy of munzij wa mushil e-balgham, majoon-e-hindi and
 
Management of ischeamic heart disease in light of advia qalbia
Management of ischeamic heart disease in light of advia qalbiaManagement of ischeamic heart disease in light of advia qalbia
Management of ischeamic heart disease in light of advia qalbia
 

Recently uploaded

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 

Recently uploaded (20)

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 

Jounral club presentation on 22 march 2014 in NATIONAL INSTITUTE OF UNANI MEDICINE, BANGALORE

  • 1. DR MOHD SHAHID DEPARTMENT OF MOLAJAT NIUM, BANGALORE
  • 2.  BMC Complementary and Alternative Medicine is an open access, peer-reviewed journal that considers articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation  Impact Factor : 2.08  ISSN: 1472-6882
  • 3.  BioMed Central is an STM (Science, Technology and Medicine) publisher of 258 peer-reviewed open access journals.  BioMed Central Floor 6, 236 Gray's Inn Road London WC1X 8HB United Kingdom Email: info@biomedcentral.com Customer Services: Customers in the UK call free on 0800 389 8136 All other customers call +44 (0) 20 3192 2009 (weekdays 9am - 6pm UK time) Fax: +44 (0)20 3192 2010
  • 4.  Indexing services All articles published in BMC Complementary and Alternative Medicine are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine  Other bibliographic databases  Google Scholar  MEDLINE
  • 5.  PubMed Central  SOCOLAR  SpringerLink  Thomson Reuters (ISI) etc...
  • 6. Received: 16 Nov 2012 Accepted: 01 Nov 2013 Published: 13 Nov 2013
  • 7.  A randomized, controlled cross-over trial of dermally- applied lavender (Lavandula angustifolia) oil as a treatment of agitated behaviour in dementia
  • 8.  Informative ?  Self Explanatory ?  Variables are Specific ?
  • 9.  Daniel W O’Connor*  Barbara Eppingstall  John Taffe  Eva S van der Ploeg  *Correspondence: Daniel.OConnor@monash.edu School of Psychology and Psychiatry, Monash University, Kingston Centre, Warrigal Road, Cheltenham, Victoria 3192, Australia
  • 10. Competent ? Degree and Designations ? E mail is mentioned
  • 11.  A progressive, irreversible decline in mental function, marked by memory impairment and, often, deficits in reasoning, judgment, abstract thought, registration, comprehension, learning, task execution, and use of language  In the U.S., 4.5 million people are afflicted by dementia. The prevalence is esp. high in the very elderly: about 20% to 40% of those over 85 are demented  Dementia is somewhat more common in women than in men
  • 12.  Synonym L. officinalis Chaix. L. spica Linn.  Family Labiatae; Lamiaceae.  Habitat Native to Mediterranean region; cultivated in Jammu and Kashmir  English name: Lavender
  • 13.  Action Herb—mildly sedative, antiflatulent and cholagogue. Essential oil— antiseptic, antibacterial, antispasmodic.  Major constituents of the essential oil are linalool and linalyl acetate.
  • 14.  Family Papilionaceae; Fabaceae.  Habitat Mediterranean region and Asia Minor. Dried plant and flowers are imported into Mumbai from Persian Gulf  English Arabian or French: Lavender  Unani: Ustukhuddus, Alfaajan  Folk: Dhaaru
  • 15.  Action Flowers— antidepressive, sedative, anticonvulsant, carminative, a ntispasmodic, antibacterial, antiseptic. Used in depression, nervous headache, sluggish circulation, physical and mental exhaustion, insomnia, epilepsy, neuralgia and rheumatic affections  Plant—used for the treatment of epilepsy and chronic sinusitis in Unani medicine.
  • 16.  BACKGROUND clearly mentioned  Objective is clearly stated (want to know efficacy of test drug )  It is a Randomized, single blind cross-over trial, mentioned in abstract  Study design is also given in abstract  Hypothesis is declare  Results also mentioned clearly that test drug is not significant against the conrol drug  Trial registration also stated (ACTRN)
  • 17.  Conclusion is comprehensible  Within the word limit  Purpose of study is well defined
  • 19.  Prevalence missing of dementia  More emphasis on Lavender  Wonderfully describe why they choose test drug with proper references.  One study quted, that describe the efficacy is equal to lorazepam0.5 mg  Literature review provided  Aim of study is mentioned  Astonishingly discussed about previous study
  • 20.  Need of study is mentioned  Purpose of study is mentioned but why they choose fore arm massage instead of head or any other part of the body, not declared
  • 21.  Palace of study point out, and also from where the participants enrolled (8 specialist Psychogeriatric nursing home and 3 private nursing home in Melbourne)  Diagnostic criteria is declare, with REFERENCE (CLINICAL DEMENTIA RATING SCALE)  Inclusion & Exclusion criteria Stated  Test drug & dosage are mentioned properly, WHY THIS DRUG---- REFERENCES given  Duration of study mentioned between 2009 and 2011)
  • 22.  Study protocol approved by IEC  Test drug choose after electrophysical analysis in Department of Pharmacology and Toxicology, Otago University, New Zealand  Not describe the control drug (just stated neutral control oil)  Follow up & total number of patient screened declared  Drop outs declared, with REASONS  Randomization done through Exel random number generator
  • 23.  Duration of protocol is also declared, that is both intervention comprised 3 exposures over a one week with 4 days washout period and the trial was limited to 2 week  Sample size declared  Group A: total allocated patients 38, number of patients complete the intervention are 37  Group B ; total allocated patients 28, number of patients complete the intervention are 27  Written consent was taken from the next of Kin or legal guardians  Study design mentioned
  • 24.  Subjective and Objective criteria point out  Tables are clearly defined, with Graphical representation  Analysis are made through 1. Two sided hypothesis test with Type I error rate 0.05 and power set to 90 2. Binomial regression test
  • 25.  Discussion about the result are justified  Mention the limitation of study 1. Product varialbility 2. Limited knowledge base of lavender’s pharmacological properties 3. Dosing strategies are based largely on traditional practice
  • 26.  Unambiguously declare that Studies of essential oils are constrained by their variable formulations and uncertain pharmacokinetics and so optimal dosing and delivery regimens remain speculative.  However this, topically delivered, high strength, pure lavender oil had no discernible effect on affect and behaviour in a well-defined clinical sample.
  • 27.  Acknowledgements are declare  Funding: By National Health and Medical Research Council and the Dementia Collaborative Reasearch Centre administered through the University of New South Wales. Neither funding body, nor the supplier of materials, played any part in analysing data and preparing this report.  Reference according to the journal guidelines
  • 28.  This is wonderful example that how to done and write a standard paper  For me, this is the way to approach a study before going to conduct it  They have given every answers before you raise any question  Wonderful paper